oncology-performance-status
karnofsky-performance
lansky-performance
ecog-performance
chemotherapy-dosage-based-on-hepatic-function
recommended-dose-reduction-for-hepatic-dysfunction
chemotherapy-dosage-based-on-renal-function
recommended-dose-reduction-for-renal-dysfunction
dialysis-of-chemotherapy-drugs
guidelines-for-dialysis-of-chemotherapy-drugs
common-chemotherapy-regimens
adrenocortical-cancer
combination-regimens
anal-cancer
combined-modality-therapy
fluorouracil-mitomycin-c-radiation-therapy-rtogecog-regimen
fluorouracil-mitomycin-c-radiation-therapy-eortc-regimen
capecitabine-mitomycin-c-radiation-therapy
fluorouracil-cisplatin-radiation-therapy
xelox-radiation-therapy
metastatic-disease---combination-regimens
fluorouracil-cisplatin
metastatic-disease---single-agent-regimens
pembrolizumab
basal-cell-cancer
single-agent-regimens
vismodegib
sonidegib
biliary-tract-cancer
combination-regimens-1
gemcitabine-cisplatin
gemcitabine-capecitabine
gemcitabine-oxaliplatin
fluorouracil-cisplatin-1
capecitabine-cisplatin
capecitabine-oxaliplatin
single-agent-regimens-1
capecitabine
docetaxel
gemcitabine
bladder-cancer
combination-regimens-2
itp
dose-dense-gemcitabine-cisplatin
gemcitabine-cisplatin-1
gemcitabine-carboplatin
gemcitabine-paclitaxel
gemcitabine-docetaxel
dose-dense-mvac
cmv
mcv
docetaxel-cisplatin
paclitaxel-carboplatin
cap
fluorouracil-mitomycin-c-radiation-therapy
single-agent-regimens-2
gemcitabine-1
paclitaxel
pemetrexed
atezolizumab
avelumab
darvalumab
nivolumab
pembrolizumab-1
brain-cancer
adjuvant-therapy---combination-regimens
temozolomide-radiation-therapy
pcv
single-agent-regimens-3
carmustine
advanced-disease---combination-regimens
pcv-1
irinotecan-bevacizumab
temozolomide-bevacizumab
carboplatin-irinotecan-bevacizumab
temozolomide-lomustine
single-agent-regimens-4
carmustine-1
procarbazine
temozolomide
irinotecan
bevacizumab
breast-cancer
neoadjuvant-therapy---combination-regimens
act
docetaxel-carboplatin-pertuzumab-trastuzumab
adjuvant-therapy---combination-regimens-her2-negative-disease
ac
act-1
act-weekly
acdocetaxel
acdocetaxel-weekly
tc
tac
caf
epirubicin-cmf
fec
fecdocetaxel
dose-dense-combination-regimens-her2-negative-disease
act-2
atc
acdocetaxel-1
docetaxelac
combination-regimens-her2-positive-disease
act-trastuzumab
act-trastuzumab-dose-dense
tch
dhfec
pertuzumab-trastuzumab-docetaxel
single-agent-regimens-5
neratinib
hormonal-regimens
tamoxifen
anastrozole
letrozole
tamoxifen-letrozole-83
tamoxifen-exemestane-84
tamoxifen-goserelin-zoledronic-acid
anastrozole-goserelin-zoledronic-acid
everolimus-exemestane-86
metastatic-disease---combination-regimens-her2-negative-disease
ac-1
at
caf-1
cef
cmf
capecitabine-docetaxel-xt
capecitabine-paclitaxel-xp
capecitabine-navelbine-xn
capecitabine-ixabepilone-xi
docetaxel-doxorubicin
doxorubicin-liposome-docetaxel
fec-100
fec-75
fec-50
gemcitabine-paclitaxel-1
carboplatin-paclitaxel
carboplatin-docetaxel
paclitaxel-bevacizumab
combination-regimens-her2-positive-disease-1
pertuzumab-trastuzumab-docetaxel-1
trastuzumab-paclitaxel
trastuzumab-docetaxel
tch-1
gemcitabine-carboplatin-trastuzumab
trastuzumab-navelbine
trastuzumab-gemcitabine
trastuzumab-capecitabine
trastuzumab-lapatinib
capecitabine-lapatinib
everolimus-exemestane-86-1
palbociclib-letrozole
ribociclib-letrozole
palbociclib-fulvestrant
abemaciclib-fulvestrant
abemaciclib-anastrozole
abemaciclib-letrozole
single-agent-regimens-6
tamoxifen-1
toremifene
anastrozole-1
letrozole-1
fulvestrant
megestrol
trastuzumab
ado-trastuzumab-emtansine
capecitabine-1
docetaxel-1
paclitaxel-1
ixabepilone
vinorelbine
doxorubicin
gemcitabine-2
doxorubicin-liposome
abraxane
eribulin
abemaciclib
olaparib
cancer-of-unknown-primary
combination-regimens-3
pce
ep
peb
gcp
gemcitabine-cisplatin-paclitaxel
gemcitabine-irinotecan
capecitabine-oxaliplatin-1
bevacizumab-erlotinib
carcinoid-tumors-and-neuroendocrine-tumors
combination-regimens-4
fluorouracil-streptozocin
doxorubicin-streptozocin
cisplatin-etoposide
everolimus-octreotide-lar
capecitabine-temozolomide
single-agent-regimens-7
octreotide
lanreotide
sunitinib
everolimus
lutetium-lu-177-dotatate
cervical-cancer
combination-regimens-5
cisplatin-radiation-therapy
paclitaxel-cisplatin
cisplatin-topotecan
paclitaxel-topotecan
paclitaxel-topotecan-bevacizumab
cisplatin-paclitaxel-bevacizumab
bip
bic
cisplatin-5-fluorouracil
cisplatin-vinorelbine
cisplatin-irinotecan
cisplatin-gemcitabine
carboplatin-docetaxel-1
cisplatin-pemetrexed
single-agent-regimens-8
docetaxel-2
paclitaxel-2
irinotecan-1
topotecan
pemetrexed-1
gemcitabine-3
pembrolizumab-2
colorectal-cancer
neoadjuvant-combined-modality-therapy-for-rectal-cancer---combination-regimens
fluorouracil-radiation-therapy-german-aio-regimen
infusion-5-fu-1-radiation-therapy
capecitabine-radiation-therapy
fulv-oxaliplatin-radiation-therapy
xelox-radiation-therapy-1
adjuvant-therapy---combination-regimens-1
fluorouracil-leucovorin-weekly-schedule-high-dose
fluorouracil-leucovorin-weekly-schedule-low-dose
oxaliplatin-1-5-fluorouracil-1-leucovorin-folfox4
oxaliplatin-5-fluorouracil-leucovorin-mfolfox7
flox
oxaliplatin-capecitabine-xelox
lv5fu2-degramont-regimen
capecitabine-2
metastatic-disease---combination-regimens-1
irinotecan-5-fluorouracil-leucovorin-modified-ifl-saltz-regimen
irinotecan-5-fluorouracil-leucovorin-douillard-regimen
irinotecan-5-fluorouracil-leucovorin-folfiri-regimen
oxaliplatin-5-fluorouracil-leucovorin-folfox4
oxaliplatin-5-fluorouracil-leucovorin-folfox6
oxaliplatin-5-fluorouracil-leucovorin-folfox7
oxaliplatin-5-fluorouracil-leucovorin-mfolfox7-1
folfoxiri
folfoxiri-bevacizumab
folfoxiri-panitumumab
cetuximab-irinotecan
capecitabine-oxaliplatin-xelox
capecitabine-irinotecan-xeliri
capecitabine-mitomycin-c
oxaliplatin-irinotecan-irox-regimen
fluorouracil-leucovorin-roswell-park-schedule-high-dose
fluorouracil-leucovorin-bevacizumab
fluorouracil-leucovorin-german-schedule-low-dose
fluorouracil-leucovorin-de-gramont-regimen
folfox4-bevacizumab
lv5fu2-mitomycin-c
capecitabine-oxaliplatin-xelox-bevacizumab
cetuximab-bevacizumab-irinotecan
cetuximab-bevacizumab
irinotecan-cetuximab
folfiri-cetuximab
folfox4-cetuximab
folfox6-cetuximab
folfox4-panitumumab
folfiri-panitumumab
folfiri-bevacizumab
xeliri-bevacizumab
folfiri-ziv-aflibercept
folfiri-ramucirumab
nivolumab-ipilimumab
hepatic-artery-infusion
floxuridine
single-agent-regimens-9
capecitabine-3
cpt-11-weekly-schedule
cpt-11-monthly-schedule
cetuximab
panitumumab
fluorouracil-continuous-infusion
regorafenib
tas-102
pembrolizumab-3
nivolumab-1
endometrial-cancer
combination-regimens-6
paclitaxel-carboplatin-1
ac-2
ap
doxorubicin-paclitaxel
cisplatin-doxorubicin-paclitaxel
cap-1
carboplatin-doxorubicin-liposome
paclitaxel-ifosfamide-carcinosarcoma
cisplatin-ifosfamide-carcinosarcoma
gemcitabine-docetaxel-1
single-agent-regimens-10
doxorubicin-1
megestrol-1
paclitaxel-3
topotecan-1
temsirolimus
esophageal-cancer
neoadjuvant-combined-modality-therapy
fluorouracil-cisplatin-radiation-therapy-prodige5accord17
folfox-radiation-therapy-prodige5accord17
capox-radiation-therapy
fluorouracil-cisplatin-radiation-therapy-ffd-french-regimen
fluorouracil-cisplatin-radiation-therapy-hopkinsyale-regimen
adjuvant-chemotherapy
magic-trial---preoperative-ecf-chemotherapy
adjuvant-chemotherapy-1
metastatic-disease---combination-regimens-2
fluorouracil-cisplatin-2
irinotecan-cisplatin
paclitaxel-cisplatin-1
capecitabine-oxaliplatin-2
ecf
eof
ecx
eox
single-agent-regimens-11
paclitaxel-4
pembrolizumab-4
gastric-cancer
adjuvant-therapy
capecitabine-oxaliplatin-3
metastatic-disease---combination-regimens-3
dcf
cf
ecf-1
eof-1
ecx-1
eox-1
ip
ipb
docetaxel-cisplatin-1
ido
capecitabine-cisplatin-1
xp-trastuzumab
fp-trastuzumab
flo
mfolfox6
paclitaxel-ramucirumab
single-agent-regimens-12
fluorouracil
fluorouracil-leucovorin
docetaxel-3
ramucirumab
pembrolizumab-5
gastrointestinal-stromal-tumor-gist
adjuvant-therapy-1
imatinib
metastatic-disease---single-agent-regimens-1
imatinib-1
nilotinib
sunitinib-1
sorafenib
regorafenib-1
head-and-neck-cancer
combined-modality-therapy-1
cetuximab-radiation-therapy
tpf-induction-chemotherapy-followed-by-carboplatin-radiation-therapy
combination-regimens-7
tip
tpf
tic
paclitaxel-carboplatin-2
paclitaxel-cisplatin-2
pf
carboplatin-5-fu
pf-cetuximab
carboplatin-5-fu-1-cetuximab
cisplatin-cetuximab
pf-larynx-preservation
concurrent-chemoradiation-therapy-for-laryngeal-preservation
chemoradiotherapy-for-nasopharyngeal-cancer
vp
single-agent-regimens-13
docetaxel-4
paclitaxel-5
methotrexate
vinorelbine-1
cetuximab-1
pembrolizumab-6
nivolumab-2
hepatocellular-cancer
combination-regimens-8
gemox
folfox4
bevacizumab-erlotinib-1
single-agent-regimens-14
sorafenib-1
regorafenib-2
doxorubicin-2
cisplatin
capecitabine-4
bevacizumab-1
pembrolizumab-7
kaposis-sarcoma
combination-regimens-9
bv
abv
single-agent-regimens-15
daunorubicin-liposome
doxorubicin-liposome-1
paclitaxel-6
docetaxel-5
etoposide
vinorelbine-2
interferon-alpha
leukemia
acute-lymphocytic-leukemia
induction-therapy---linker-regimen-338-339
consolidation-therapy---linker-regimen-338-339
maintenance-therapy---linker-regimen-338-339
cns-prophylaxis
induction-therapy---larson-regimen-340
hyper-cvad-regimen
cns-prophylaxis-1
supportive-care
single-agent-regimens-16
clofarabine
nelarabine
imatinib-2
dasatinib
nilotinib-1
blinatumomab
inotuzumab
acute-myelogenous-leukemia---induction-regimens
ara-c-daunorubicin-7-3-349
liposomal-daunorubicin-and-cytarabine-350
ara-c-daunorubicin-gemtuzumab-351
ara-c-idarubicin-352
ara-c-doxorubicin-353
ara-c-clofarabine
ara-c-daunorubicin-midostaurin
consolidation
maintenance
aida-acute-promyelocytic-leukemia-only-356
tretinoin-daunorubicin-cytarabine-acute-promyelocytic-leukemia-357
tretinoin-arsenic-trioxide-acute-promyelocytic-leukemia-358
mitoxantrone-etoposide-salvage-regimen-359
flag
consolidation-regimens
ara-c-daunorubicin-5-1-2-361
liposomal-daunorubicin-and-cytarabine-350-1
ara-c-idarubicin-362
single-agent-regimens-17
cladribine-363
high-dose-cytarabine
clofarabine-1
tretinoin-acute-promyelocytic-leukemia-only-366
arsenic-trioxide-acute-promyelocytic-leukemia-only
sorafenib-2
azacitidine
decitabine
enasidenib
chronic-lymphocytic-leukemia---combination-regimens
cvp
cf-1
fp
cp
fr
fcr
pcr
bendamustine-rituximab
venetoclax-rituximab
idelasib-rituximab-382
obinutuzumab-chlorambucil
single-agent-regimens-18
alemtuzumab
chlorambucil
cladribine
fludarabine
prednisone
rituximab
ofatumumab
pentostatin
bendamustine
lenalidomide
ibrutinib
venetoclax
chronic-myelogenous-leukemia---combination-regimens
interferon-cytarabine
chronic-myelogenous-leukemia---single-agent-regimens
imatinib-3
dasatinib-1
nilotinib-2
bosutinib
ponatinib
busulfan
hydroxyurea
interferon-alpha-2a
omacetaxine
hairy-cell-leukemia---single-agent-regimens
cladribine-1
pentostatin-1
interferon-alpha-2a-1
lung-cancer
nonsmall-cell-lung-cancer---combined-modality-therapy
cisplatin-etoposide-radiation-therapy
weekly-carboplatin-paclitaxel-radiation-therapy
adjuvant-therapy---combination-regimens-2
paclitaxel-carboplatin-3
vinorelbine-cisplatin
cisplatin-vinblastine
etoposide-cisplatin
pemetrexed-cisplatin
metastatic-disease---combination-regimens-4
carboplatin-paclitaxel-pc
carboplatin-nab-paclitaxel
carboplatin-paclitaxel-weekly-regimen
carboplatin-paclitaxel-bevacizumab-pcb
gemcitabine-cisplatin-bevacizumab-gcb
cisplatin-paclitaxel
docetaxel-carboplatin
docetaxel-cisplatin-2
docetaxel-gemcitabine
gemcitabine-cisplatin-2
gemcitabine-carboplatin-1
gemcitabine-vinorelbine
vinorelbine-cisplatin-1
vinorelbine-cisplatin-cetuximab
vinorelbine-carboplatin
pemetrexed-cisplatin-1
pemetrexed-carboplatin
ep-1
ep-docetaxel
docetaxel-bevacizumab
pemetrexed-carboplatin-bevacizumab
pemetrexed-carboplatin-pembrolizumab
pemetrexed-cisplatin-pembrolizumab
cisplatin-vinorelbine-cetuximab
platinum-based-chemotherapy-maintenance-pemetrexed-non-squamous-histology
nab-paclitaxel-carboplatin
docetaxel-ramucirumab
gemcitabine-cisplatin-necitumumab
dabrafenib-trametinib
carboplatin-paclitaxel-pembrolizumab
carboplatin-nab-paclitaxel-pembrolizumab
metastatic-disease---single-agent-regimens-2
paclitaxel-7
nab-paclitaxel
docetaxel-6
pemetrexed-2
gemcitabine-4
vinorelbine-3
gefitinib
erlotinib
afatinib
sunitinib-2
cetuximab-2
nivolumab-3
crizotinib
ceritinib
alectinib
brigatinib
osimertinib
pembrolizumab-8
durvalumab
small-cell-lung-cancer---combination-regimens
ep-2
ec
irinotecan-cisplatin-1
topotecan-cisplatin
carboplatin-paclitaxel-etoposide
carboplatin-paclitaxel-1
cav
cae
small-cell-lung-cancer---single-agent-regimens
etoposide-1
paclitaxel-8
topotecan-2
gemcitabine-5
lymphoma
hodgkins-lymphoma---combination-regimens
abvd
a-avd
mopp
moppabvd-hybrid
mopp-alternating-with-abvd
stanford-v
eva
evap
mini-beam
beacopp
beacopp-escalated
gvd
hodgkins-lymphoma---single-agent-regimens
gemcitabine-6
rituximab-1
brentuximab
nivolumab-4
pembrolizumab-9
bendamustine-1
everolimus-1
lenalidomide-1
non-hodgkins-lymphoma---low-grade-lymphoma---combination-regimens
cvp-1
chop
cnop
fnd
fc
fcr-1
r-chop
r-fcm
bendamustine-rituximab-1
bortezomib-mantle-cell-lymphoma
ibrutinib-mantle-cell-lymphoma
acalabrutinib-mantle-cell-lymphoma
copanlisib
bendamustine-obinutuzumab
non-hodgkins-lymphoma---intermediate-grade-lymphoma
chop-1
chop-rituximab
r-chop-14
cnop-1
epoch
epoch-rituximab
macop-b
m-bacod
promacecytabom
eshap-salvage-regimen
dhap-salvage-regimen
ice-salvage-regimen
rice-salvage-regimen
mine-salvage-regimen
r-gemox
non-hodgkins-lymphoma---high-grade-lymphoma
magrath-protocol-burkitts-lymphoma
regimen-a-codox-m-530
cns-prophylaxis-2
regimen-b-ivac
stanford-regimen-small-noncleaved-cell-and-burkitts-lymphoma
hyper-cvadmethotrexate-ara-c
intrathecal-chemotherapy-prophylaxis
axicabtagene-ciloceucel-533
tisagenlecleucel-534
single-agent-regimens-19
rituximab-2
ibritumomab-tiuxetan-regimen
fludarabine-1
cladribine-2
bendamustine-2
vorinostat-peripheral-t-cell-lymphoma
pralatrexate
brentuximab-1
romidepsin-peripheral-t-cell-lymphoma
belinostat-peripheral-t-cell-lymphoma
bortezomib-mantle-cell-lymphoma-1
lenalidomide-mantle-cell-lymphoma
pembrolizumab-10
primary-cns-lymphoma
combination-regimens-10
r-mpv-radiation-therapy-cytarabine
single-agent-regimens-20
high-dose-methotrexate
temozolomide-1
topotecan-3
prostate-cancer
staging-system-for-prostate-cancer
definitions-for-t-n-m---prostate-cancer
ajcc-prognostic-groups---prostate-cancer
diagnosis---prostate-cancer
initial-prostate-cancer-diagnosis
initial-risk-stratification-and-staging-workup---prostate-cancer
treatment---prostate-cancer
systemic-therapy-for-castration-naive-prostate-cancer
systemic-therapy-for-m0-castration-resistant-prostate-cancer-crpc
systemic-therapy-for-m1-castration-resistant-prostate-cancer-crpc
principles-of-genetics---prostate-cancer
germline-testing
somatic-tumor-testing
principles-of-imaging---prostate-cancer
goals-of-imaging
efficacy-of-imaging
plain-radiography
ultrasound
bone-imaging
computed-tomography
magnetic-resonance-imaging
positron-emission-tomography-pet
principles-of-active-surveillance-and-observation
advantages-of-active-surveillance
disadvantages-of-active-surveillance
advantages-of-observation
disadvantages-of-observation
principles-of-radiation-therapy
principles-of-surgery
principles-of-androgen-deprivation-therapy
adt-for-clinically-localized-n0m0-disease
adt-for-regional-n1m0-disease
adt-for-pn1-disease
adt-for-m0-psa-persistencerecurrence-after-rp-or-ebrt-adt-for-m0-castration-naïve-disease
adt-for-metastatic-castration-naïve-disease
secondary-hormone-therapy-for-m0-or-m1-crpc
section
icd-10-cm
國際疾病分類第十版中英對照檢索
tfda-atc
藥品藥理治療分類-atc-code
tfda-ahfsdi
藥品藥理治療分類-ahfsdi-code
frequently-used-links
醫藥參考
醫藥文獻
藥物辨識
藥品給付
memo
daily
code
